about
sameAs
The efficacy of the ultraviolet C pathogen inactivation system in the reduction of Babesia divergens in pooled buffy coat plateletsCha, a basic helix-loop-helix transcription factor involved in the regulation of upstream stimulatory factor activity.Altered bone marrow lymphopoiesis and interleukin-6-dependent inhibition of thymocyte differentiation contribute to thymic atrophy during Trypanosoma cruzi infection.Detection of the amoeba Entamoeba gingivalis in periodontal pockets.Global metabolomic profiling of acute myocarditis caused by Trypanosoma cruzi infectionTrypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes.Analysis of the dynamics of infiltrating CD4(+) T cell subsets in the heart during experimental Trypanosoma cruzi infectionThe Trypanosoma cruzi satellite DNA OligoC-TesT and Trypanosoma cruzi kinetoplast DNA OligoC-TesT for diagnosis of Chagas disease: a multi-cohort comparative evaluation study.Cytokine profiling in Chagas disease: towards understanding the association with infecting Trypanosoma cruzi discrete typing units (a BENEFIT TRIAL sub-study).Nonimmune Cells Contribute to Crosstalk between Immune Cells and Inflammatory Mediators in the Innate Response to Trypanosoma cruzi InfectionCyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-statusFasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia.Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' diseaseImmune suppression in advanced chronic fascioliasis: an experimental study in a rat model.Antibodies to an epitope from the Cha human autoantigen are markers of Chagas' disease.A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses.A point mutation in the cytoplasmic domain of the transferrin receptor inhibits endocytosis.Correction: Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?Spleen B cells from BALB/c are more prone to activation than spleen B cells from C57BL/6 mice during a secondary immune response to cruzipain.Genome Sequence of Trypanosoma cruzi Strain Bug2148.L-arginine supplementation reduces mortality and improves disease outcome in mice infected with Trypanosoma cruzi.The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma.Anaemia in advanced chronic fasciolosis.The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets.Regulatory Lymphoid and Myeloid Cells Determine the Cardiac Immunopathogenesis of Trypanosoma cruzi Infection.Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection.Trypanosoma cruzi strains cause different myocarditis patterns in infected miceInducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophagesRole of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathologyComparative proteomic analysis of trypomastigotes from Trypanosoma cruzi strains with different pathogenicity
P50
Q28236676-4DCA920D-779B-4290-A0D8-74DD25FB4E2AQ31814884-BBC20B4E-E78F-4C60-A74A-103EF200825DQ33566563-2507852B-5803-4CB3-B98C-DE37C2BC16D9Q33829304-15E17F26-4DD7-4F83-8A5E-E99E0C1F2F43Q34549735-657C8EC6-0D3E-4097-8E23-7876E2DA5812Q34587039-66B05230-DF0E-41BD-864D-8B872B615E70Q34775976-FF5DE14D-02DA-4D53-BDC2-04D7B30BCD48Q35083540-E1E760C5-5122-4341-8236-700103A733C6Q35114499-0782343D-F3BD-4FFE-BA88-212AB570993FQ35173250-4ACD1B7E-506D-48D4-9629-CE1A768CAC6DQ35754864-248BFDAB-C6D4-4C4E-B41E-3BAC35A9FDD6Q36317381-32CA10F9-ECF8-4D26-9FBA-EB67DEE08AE7Q36330066-83FFC58F-6569-4A93-8104-0E8145874362Q36966175-4200CE7D-0492-419F-9D04-A671B20031F4Q39024642-A53002EF-A876-4DA2-AF89-4851E654ED3CQ39508836-697A4C3B-A819-4063-A9F9-D397C9DDB0E5Q40085004-77F7995B-5C97-401C-A6D3-8A3E5B80372DQ41228099-B0FEBD23-51C6-4363-82F2-E74C1F642096Q43203433-C873698E-717A-46D0-B023-5285AFB6ECE8Q43890969-DE57C74F-8965-4C06-93FB-6E32A5FDF029Q46927499-9638B11D-2024-4AAB-8398-E43686B99252Q48216268-7A83515B-E215-43F0-AC69-E1D6A6191FDDQ48235481-D8C4F58F-2F26-4EC3-B32E-3952E9A9A586Q50474223-2AEA91C4-4349-4C80-8F01-8FDF893D264FQ50634400-6261AAAD-7332-4F5D-83C9-49C220C9B426Q50704130-8CD23E8F-D344-4861-B391-B8CB2B3F9DBBQ54255041-E1CC01A5-62C6-4E6B-B6B7-63B220BEC925Q54356491-DABAE75A-54B4-41CB-9F28-027630E6E85DQ58842839-473A3AAC-C907-44AC-8F51-DAE961E26E50Q58844652-6952E39F-92D0-4718-A4FE-AD03B87C548BQ58844932-843AC74F-5AFA-49AC-B81F-B337C7240A7BQ90179845-84535159-8BAC-4992-8A85-46F1986833B3
P50
description
Spaans onderzoekster
@nl
researcher ORCID ID = 0000-0002-8130-2750
@en
spanische Forscherin
@de
name
Núria Gironès
@ast
Núria Gironès
@en
Núria Gironès
@es
Núria Gironès
@ga
Núria Gironès
@nl
Núria Gironès
@sl
type
label
Núria Gironès
@ast
Núria Gironès
@en
Núria Gironès
@es
Núria Gironès
@ga
Núria Gironès
@nl
Núria Gironès
@sl
prefLabel
Núria Gironès
@ast
Núria Gironès
@en
Núria Gironès
@es
Núria Gironès
@ga
Núria Gironès
@nl
Núria Gironès
@sl
P1053
L-7865-2017
P106
P1153
6602509140
P21
P27
P2798
P31
P3829
P496
0000-0002-8130-2750